Fulcrum Therapeutics (FULC) PT Raised at Piper Sandler Post Positive 20mg Pociredir Data
Tweet Send to a Friend
Piper Sandler analyst Edward A. Tenthoff raised the price target on Fulcrum Therapeutics (NASDAQ: FULC) to $23.00 (from $16.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
